Martin Becker

Martin Becker

Auto-generated profile, based on publicly available information

Martin Becker

Centre for Psychiatry Research 1 Center of Neurodevelopmental Disorders (KIND) Department of Women's and Children's Health 17164 Stockholm , Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EJEmma Jaeger
Emma Jaeger
SLSimon Leedham
Simon Leedham
ALAnnabelle Lewis
Annabelle Lewis
SSStefania Segditsas
Stefania Segditsas
MBMartin Becker
Martin Becker
ITIan Tomlinson
Ian Tomlinson
Ian Tomlinson and colleagues identify a 40-kb duplication upstream of the gene that encodes the BMP antagonist GREM1 in families with hereditary mixed polyposis syndrome. The mutation is associated with increased allele-specific and ectopic expression of GREM1. Hereditary mixed polyposis syndrome (HMPS) is characterized by apparent autosomal dominant inheritance of multiple types of colorectal polyp, with colorectal carcinoma occurring in a high proportion of affected individuals. Here, we use genetic mapping, copy-number analysis, exclusion of mutations by high-throughput sequencing, gene expression analysis and functional assays to show that HMPS is caused by a duplication spanning the 3′ end of the SCG5 gene and a region upstream of the GREM1 locus. This unusual mutation is associated with increased allele-specific GREM1 expression. Whereas GREM1 is expressed in intestinal subepithelial myofibroblasts in controls, GREM1 is predominantly expressed in the epithelium of the large bowel in individuals with HMPS. The HMPS duplication contains predicted enhancer elements; some of these interact with the GREM1 promoter and can drive gene expression in vitro. Increased GREM1 expression is predicted to cause reduced bone morphogenetic protein (BMP) pathway activity, a mechanism that also underlies tumorigenesis in juvenile polyposis of the large bowel.

20 August 2015 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
MBMartin Becker
Martin Becker
PDPaolo Devanna
Paolo Devanna
SFSimon E. Fisher
Simon E. Fisher
SVSonja C. Vernes
Sonja C. Vernes
Mutations of FOXP2 in 7q31 cause a rare disorder involving speech apraxia, accompanied by expressive and receptive language impairments. A recent report described a child with speech and language deficits, and a genomic rearrangement affecting chromosomes 7 and 11. One breakpoint mapped to 7q31 and, although outside its coding region, was hypothesised to disrupt FOXP2 expression. We identified an element 2 kb downstream of this breakpoint with epigenetic characteristics of an enhancer. We show that this element drives reporter gene expression in human cell-lines. Thus, displacement of this element by translocation may disturb gene expression, contributing to the observed language phenotype.

1 August 2014 in Cell Reports
Verified
Journal Article
Open access
ALAnnabelle Lewis
Annabelle Lewis
LFLuke Freeman-Mills
Luke Freeman-Mills
ECElisa de la Calle-Mustienes
Elisa de la Calle-Mustienes
Rosa María Giráldez-PérezRosa María Giráldez-Pérez
Rosa María Giráldez-Pérez
HDHayley Davis
Hayley Davis
ITIan Tomlinson
Ian Tomlinson
A rare germline duplication upstream of the bone morphogenetic protein antagonist GREM1 causes a Mendelian-dominant predisposition to colorectal cancer (CRC). The underlying disease mechanism is strong, ectopic GREM1 overexpression in the intestinal epithelium. Here, we confirm that a common GREM1 polymorphism, rs16969681, is also associated with CRC susceptibility, conferring ∼20% differential risk in the general population. We hypothesized the underlying cause to be moderate differences in GREM1 expression. We showed that rs16969681 lies in a region of active chromatin with allele- and tissue-specific enhancer activity. The CRC high-risk allele was associated with stronger gene expression, and higher Grem1 mRNA levels increased the intestinal tumor burden in Apc(Min) mice. The intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.

14 September 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MBMartin Becker
Martin Becker
FMFrancesca Mastropasqua
Francesca Mastropasqua
JRJan Philipp Reising
Jan Philipp Reising
SMSimon Maier
Simon Maier
MHMai-Lan Ho
Mai-Lan Ho
KTKristiina Tammimies
Kristiina Tammimies
CASK-related disorders are genetically defined neurodevelopmental syndromes. There is limited information about the effects ofCASKmutations in human neurons. Therefore, we sought to delineateCASK-mutation consequences and neuronal effects using induced pluripotent stem cell-derived neurons from two mutation carriers. One male case with autism spectrum disorder carried a novel splice-site mutation and a female case with intellectual disability carried an intragenic tandem duplication. We show reduction of CASK protein in maturing neurons from the mutation carriers, which leads to significant downregulation of genes involved in presynaptic development and of CASK protein interactors. Furthermore,CASK-deficient neurons showed decreased inhibitory presynapse size as indicated by VGAT staining, which may alter the excitatory–inhibitory (E/I) balance in developing neural circuitries. Using in vivo magnetic resonance spectroscopy quantification of GABA in the male mutation carrier, we further highlight the possibility to validate in vitro cellular data in the brain. Our data show that future pharmacological and clinical studies on targeting presynapses and E/I imbalance could lead to specific treatments forCASK-related disorders.

27 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
MKMagdalena Kurek
Magdalena Kurek
EAElisabet Akesson
Elisabet Akesson
MYMasahito Yoshihara
Masahito Yoshihara
EOElizabeth Oliver
Elizabeth Oliver
YCYanhua Cui
Yanhua Cui
JSJan Bernd Stukenborg
Jan Bernd Stukenborg
Fertility preservation for male childhood cancer survivors not yet capable of producing mature spermatozoa, relies on experimental approaches such as testicular explant culture. Although the first steps in somatic maturation can be observed in human testicular explant cultures, germ cell depletion is a common obstacle. Hence, understanding the spermatogonial stem cell (SSC) niche environment and in particular, specific components such as the seminiferous basement membrane (BM) will allow progression of testicular explant cultures. Here, we revealed that the seminiferous BM is established from 6 weeks post conception with the expression of laminin alpha 1 (LAMA 1) and type IV collagen, which persist as key components throughout development. With prepubertal testicular explant culture we found that seminiferous LAMA 1 expression is disrupted and depleted with culture time correlating with germ cell loss. These findings highlight the importance of LAMA 1 for the human SSC niche and its sensitivity to culture conditions.

21 February 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
MBMartin Becker
Martin Becker
PDPaolo Devanna
Paolo Devanna
SFSimon E. Fisher
Simon E. Fisher
SVSonja C. Vernes
Sonja C. Vernes
Mutations of the FOXP2 gene cause a severe speech and language disorder, providing a molecular window into the neurobiology of language. Individuals with FOXP2 mutations have structural and functional alterations affecting brain circuits that overlap with sites of FOXP2 expression, including regions of the cortex, striatum, and cerebellum. FOXP2 displays complex patterns of expression in the brain, as well as in non-neuronal tissues, suggesting that sophisticated regulatory mechanisms control its spatio-temporal expression. However, to date, little is known about the regulation of FOXP2 or the genomic elements that control its expression. Using chromatin conformation capture (3C), we mapped the human FOXP2 locus to identify putative enhancer regions that engage in long-range interactions with the promoter of this gene. We demonstrate the ability of the identified enhancer regions to drive gene expression. We also show regulation of the FOXP2 promoter and enhancer regions by candidate regulators – FOXP family and TBR1 transcription factors. These data point to regulatory elements that may contribute to the temporal- or tissue-specific expression patterns of human FOXP2. Understanding the upstream regulatory pathways controlling FOXP2 expression will bring new insight into the molecular networks contributing to human language and related disorders.